New Pattern of Retinal Laser Treatment for PDR
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorEye & ENT Hospital of Fudan University
About this trial
The objective of the study is to evaluate the efficacy of a new pattern of argon-laser in treating patients with proliferative diabetic retinopathy (PDR).
Eligibility criteria
Qualifiers
Having given free and informed consent to take part in the study.
Diabetes mellitus (DM) under stable treatment during the study, aged 18y to 70y, with no significant underlying systemic diseases (such as impaired renal function, severe cardiac disease, etc.);
Clinically diagnosed PDR, with the presence of neovascularization confirmed by ultra-widefield fundus photography and widefield OCT angiography.
Disqualifiers
Previous treatment with PRP;
Previous treatment with anti-VEGF agents or corticosteroids within 3 months;
Trial design
Treatments tested in this trial
- A new pattern of retinal laser
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov